Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
iPS Cell Differentiation01:22

iPS Cell Differentiation

3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

835
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
835
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

3.3K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.3K
Stem Cell Culture01:17

Stem Cell Culture

6.0K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
6.0K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What Is a Clinically Meaningful Change in Diabetes Distress? Findings for Diabetes Care and Research From the SFDT1 Cohort.

Diabetes, obesity & metabolism·2026
Same author

Inter-Regional Center for Automated Insulin in Diabetes (CIRDIA) and Hospital-Based Approaches to Closed-Loop Therapy in Type 1 Diabetes: Cost-Effectiveness Analysis.

JMIR diabetes·2026
Same author

Safety and glycemic outcomes of DBLG1 coupled to the DANA-i pump in adults and adolescents with type 1 diabetes mellitus. The SP8 trial.

Journal of endocrinological investigation·2025
Same author

Impact of Algorithmic Modifications Targeting the Meal Period and the Management of Hypoglycemia and Hyperglycemia in Adult Persons With Type 1 Diabetes Using Closed-Loop Insulin Delivery: A Two-Step Observational Report.

Journal of diabetes science and technology·2025
Same author

Impact of photobiomodulation on beta cells and Islets under stress conditions.

Acta diabetologica·2025
Same author

Should glycaemic variability and times spent in levels 1 and 2 hypoglycaemia be revised downward in type 1 diabetes treated with advanced systems of insulin delivery?

Diabetes, obesity & metabolism·2025

Related Experiment Video

Updated: Jan 6, 2026

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

6.1K

Cell therapy for type 1 diabetes: Tracing historical progress and exploring emerging technologies.

Quentin Perrier1, Sandrine Lablanche2, Pierre-Yves Benhamou2

  • 1Univ. Grenoble Alpes, Inserm U1055, Department of pharmacy, Grenoble Alpes University Hospital, LBFA, Grenoble, France.

Cell Transplantation
|November 22, 2025
PubMed
Summary

Cell therapies offer new hope for type 1 diabetes, aiming to restore insulin independence and improve glucose control. Overcoming immune rejection and ensuring long-term cell function are key to making these treatments a reality.

Keywords:
cell therapydiabetesislet transplantationstem-celltechnology

More Related Videos

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

2.2K
Isolation, Culture, and Imaging of Human Fetal Pancreatic Cell Clusters
08:09

Isolation, Culture, and Imaging of Human Fetal Pancreatic Cell Clusters

Published on: May 18, 2014

14.7K

Related Experiment Videos

Last Updated: Jan 6, 2026

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

6.1K
Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

2.2K
Isolation, Culture, and Imaging of Human Fetal Pancreatic Cell Clusters
08:09

Isolation, Culture, and Imaging of Human Fetal Pancreatic Cell Clusters

Published on: May 18, 2014

14.7K

Area of Science:

  • Endocrinology and Metabolism
  • Immunology
  • Regenerative Medicine

Background:

  • Type 1 diabetes is an autoimmune disease with ongoing challenges in glucose management and quality of life despite insulin therapies.
  • Beta-cell replacement strategies, including islet transplantation, show promise but face limitations like donor scarcity and immunosuppression requirements.

Purpose of the Study:

  • To review current advancements and future directions in cell-based therapies for type 1 diabetes.
  • To highlight strategies addressing immune barriers and improving cell engraftment and function.

Main Methods:

  • Review of current research in stem cell-derived therapies, islet encapsulation, xenotransplantation, and gene-editing for type 1 diabetes.
  • Analysis of challenges in manufacturing, delivery, engraftment, and long-term efficacy of cell therapies.

Main Results:

  • Stem cell-derived islets demonstrate potential for insulin independence and glycemic control.
  • Encapsulation, iPSC-based therapies, and gene editing are being explored to mitigate immune rejection.
  • Porcine islet xenotransplantation is under renewed investigation, facing regulatory and immunological challenges.

Conclusions:

  • Cell therapies are transitioning towards clinical reality for type 1 diabetes, offering transformative potential.
  • Scalable manufacturing, safe delivery, regulatory approval, and patient-centric approaches are crucial for successful implementation.
  • Addressing immune barriers and ensuring long-term cell function are paramount for widespread therapeutic impact.